Vaccines

In a recent study, researchers evaluated the timeliness of vaccination among young children for several important vaccines including primary vaccines, polio, and the first dose of measles, mumps, and...

Researchers investigated the efficacy of a new live single-dose oral cholera vaccine compared with the standard 2-dose vaccine among individuals living in high-risk cholera epidemic areas in a recent...

While PCV13 is recommended for adults aged 65 years or older to prevent community-acquired pneumonia, it is not recommended for healthy adults younger than age 50 years with comorbidities that put them at...

Currently, little data exists about the impact of the serogroup B meningococcal vaccines MenB-FHbp and MenB-4C on meningococcal carriage and herd protection.

A recent report from the CDC has indicated that the 2017-2018 influenza season has started early, and the current vaccine may not be effective.

Researchers conducted a survey across 5 countries to examine immunization rates among adults, and potential factors responsible for low vaccination rates.

The risk for herpes zoster is known to increase with age. Previous evidence has indicated that the herpes zoster recombinant subunit vaccine is highly effective in preventing the virus in adults age 50...

To help improve HBV care, the American College of Physicians and Centers for Disease Control and Prevention have developed new best practice guidance for hepatitis B vaccination and screening.

In a recent study, researchers investigated the safety and immunogenicity of norovirus vaccine candidate formulations among health adults.

In a recent study, researchers evaluated the effectiveness of the influenza vaccine over the course of 4 influenza seasons through 2014.